Cowen And Company, LLC Uni Qure N.V. Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$29.24 - $42.03 $520,442 - $748,091	-17,799 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$35.35 - $50.67 $72,608 - $104,076	2,054 Added 13.05%	17,799 $643,000
Q3 2020 Nov 03, 2020	BUY	$35.98 - $47.66 $566,505 - $750,406	15,745 New	15,745 $580,000
Q2 2020 Aug 13, 2020	SELL	$45.06 - $67.74 $1.38 Million - $2.07 Million	-30,599 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$40.01 - $73.97 $1.22 Million - $2.26 Million	30,599 New	30,599 $1.45 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.